UBS Group’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.26M | Buy |
855,302
+527,887
|
|
||||
|
2025
Q1 | $861K | Sell |
327,415
-709,864
|
|
||||
|
2024
Q4 | $3.67M | Buy |
1,037,279
+1,017,775
|
|
||||
|
2024
Q3 | $88.9K | Buy |
19,504
+10,734
|
|
||||
|
2024
Q2 | $38.1K | Sell |
8,770
-25,464
|
|
||||
|
2024
Q1 | $172K | Buy |
34,234
+4,739
|
|
||||
|
2023
Q4 | $185K | Buy |
29,495
+14,963
|
|
||||
|
2023
Q3 | $103K | Sell |
14,532
-2,165
|
|
||||
|
2023
Q2 | $170K | Buy |
+16,697
|
|
||||
|
2023
Q1 | – | Sell |
-3,090
|
|
||||
|
2022
Q4 | $22.2K | Buy |
+3,090
|
|
||||
|
2022
Q3 | – | Sell |
-2,152
|
|
||||
|
2022
Q2 | $10K | Buy |
2,152
+1,152
|
|
||||
|
2022
Q1 | $6K | Sell |
1,000
-1,253
|
|
||||
|
2021
Q4 | $11K | Buy |
2,253
+1,410
|
|
||||
|
2021
Q3 | $6K | Buy |
843
+139
|
|
||||
|
2021
Q2 | $4K | Sell |
704
-1,680
|
|
||||
|
2021
Q1 | $16K | Buy |
2,384
+661
|
|
||||
|
2020
Q4 | $9K | Buy |
1,723
+992
|
|
||||
|
2020
Q3 | $5K | Sell |
731
-1,014
|
|
||||
|
2020
Q2 | $13K | Buy |
1,745
+1,403
|
|
||||
|
2020
Q1 | $3K | Sell |
342
-1,439
|
|
||||
|
2019
Q4 | $10K | Buy |
+1,781
|
|
||||
|
2019
Q3 | – | Sell |
-4,211
|
|
||||
|
2019
Q2 | $13K | Buy |
4,211
+1,551
|
|
||||
|
2019
Q1 | $8K | Sell |
2,660
-19,082
|
|
||||
|
2018
Q4 | $82K | Buy |
21,742
+19,915
|
|
||||
|
2018
Q3 | $11K | Buy |
1,827
+156
|
|
||||
|
2018
Q2 | $9K | Buy |
+1,671
|
|
||||
|
2018
Q1 | – | Sell |
-1,108
|
|
||||
|
2017
Q4 | $13K | Buy |
+1,108
|
|